Ana Barreira-Diaz

7PUBLICATIONS
48CO-AUTHORS
Cardiology (incl. cardiovascular diseases)HaematologyCellular immunologyAutoimmunityEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Rui Huang, Ai-Thien Do, Hidenori Toyoda

|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.

Mar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban

|Feb 08, 2024
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.

Mar Riveiro-Barciela, Ana Barreira-Díaz, María-Teresa Salcedo

|Dec 19, 2023
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study.

Anna Feliu-Prius, Ana Barreira-Díaz, Ariadna Rando

|Jan 10, 2023
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.

Álvaro Díaz-González, Manuel Hernández-Guerra, Indhira Pérez-Medrano

|Dec 23, 2022
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona.

Ana Barreira Díaz, Ariadna Rando, Anna Feliu-Prius

Pageof 2

Frequent Collaborators

4 joint publications

Mar Riveiro-Barciela

3 joint publications

Juan-Carlos Ruiz-Cobo

2 joint publications

Carlos Ferre-Aracil

2 joint publications

Montserrat García-Retortillo